NCT01330030View on ClinicalTrials.gov

Selegiline Patch for Treatment of Nicotine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

July 31, 2011

Conditions
Tobacco Use Disorder
Interventions
DRUG

Selegiline

6mg/24 hrs for 8 weeks

OTHER

matching placebo

placebo/24hrs for 8 weeks

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Stanford University

OTHER

NCT01330030 - Selegiline Patch for Treatment of Nicotine Dependence | Biotech Hunter | Biotech Hunter